Howard Horn insider trades

Open-market stock purchases and sales by Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical Inc, from SEC Form 4 filings since Oct 10, 2019.

Recent trades

DateStockTradeValue
Oct 15, 2026RARE Ultragenyx Pharmaceutical IncSold$108K
Aug 3, 2026RARE Ultragenyx Pharmaceutical IncSold$117K
Jul 1, 2026RARE Ultragenyx Pharmaceutical IncSold$156K
Jun 1, 2026RARE Ultragenyx Pharmaceutical IncSold$111K
May 1, 2026RARE Ultragenyx Pharmaceutical IncSold$117K
Apr 16, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Apr 16, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Apr 1, 2026RARE Ultragenyx Pharmaceutical IncSold$98.2K
Mar 3, 2026RARE Ultragenyx Pharmaceutical IncSold$36.6K
Mar 2, 2026RARE Ultragenyx Pharmaceutical IncSold$121K
Mar 2, 2026RARE Ultragenyx Pharmaceutical IncSold$70.3K
Mar 1, 2026RARE Ultragenyx Pharmaceutical IncBought (not open market)—
Feb 2, 2026RARE Ultragenyx Pharmaceutical IncSold$72.1K
Jan 2, 2026RARE Ultragenyx Pharmaceutical IncSold$71.9K
Dec 10, 2025RARE Ultragenyx Pharmaceutical IncSold$112K

Companies traded

  • RARE Ultragenyx Pharmaceutical Inc: 15 sales, last Oct 15, 2026
  • VIR Vir Biotechnology, Inc: 12 sales, last Feb 23, 2023

Get free alerts when Howard Horn files a new trade →